The association of cardioprotective medications with pneumonia-related outcomes.
about
Pneumonia, thrombosis and vascular diseaseAngiotensin-Converting Enzyme Inhibitors and Active Tuberculosis: A Population-Based Study.Is There Potential for Repurposing Statins as Novel Antimicrobials?Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD.
P2860
The association of cardioprotective medications with pneumonia-related outcomes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The association of cardioprotective medications with pneumonia-related outcomes.
@en
The association of cardioprotective medications with pneumonia-related outcomes.
@nl
type
label
The association of cardioprotective medications with pneumonia-related outcomes.
@en
The association of cardioprotective medications with pneumonia-related outcomes.
@nl
prefLabel
The association of cardioprotective medications with pneumonia-related outcomes.
@en
The association of cardioprotective medications with pneumonia-related outcomes.
@nl
P2093
P2860
P1433
P1476
The association of cardioprotective medications with pneumonia-related outcomes
@en
P2093
Antonio Anzueto
Chester Good
John R Downs
Michael J Fine
P2860
P304
P356
10.1371/JOURNAL.PONE.0085797
P407
P577
2014-01-28T00:00:00Z